Skip to content

Testing a Registry-Based Strategy (ACT+) to Reduce Loss to Follow-Up in Rheumatic Heart Disease Screening in Uganda

Developing and Testing a Registry-Enabled Strategy (ACT+) to Reduce Loss to Follow-Up Between Screening and Confirmation of Rheumatic Heart Disease in Uganda

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07606131
Acronym
SHIELD 2
Enrollment
16
Registered
2026-05-26
Start date
2026-08-01
Completion date
2028-06-01
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatic Heart Disease

Keywords

Rheumatic heart disease, SHIELD

Brief summary

This study aims to improve follow-up care after positive rheumatic heart disease (RHD) screening in Northern Uganda. It will identify barriers and co-develop an enhanced ACT+ strategy, then evaluate its effectiveness in increasing linkage to confirmatory echocardiography, along with its adoption, acceptability, and feasibility. Secondary outcomes include time to diagnosis, initiation of treatment, and factors influencing implementation.

Interventions

OTHERThe ACT+ Strategy

The Active Community Case Management Tool (ACT) is a cloud-based, dynamic RHD case management tool developed by CCHMC in partnership with global stakeholders, including UHI and the RRCU. ACT provides real-time data on patient status, clinical outcomes, and care processes, supporting both individual patient management (electronic medical record functions) and system-level quality improvement (registry and dashboard functions).

Sponsors

Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER
Uganda Heart Institute
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Intervention model description

This study employs a sequential, mixed-methods design with two phases corresponding to Aims 1 and 2. Aim 1 - Human-Centered Design (HCD) (Year 1) Aim 1 will use a theory-informed HCD framework to adapt the ACT registry and develop implementation strategies tailored to the Ugandan context. Aim 2 - Hybrid Effectiveness-Implementation Trial (Year 2) Aim 2 will evaluate ACT+ using a mixed-methods, hybrid effectiveness-implementation trial with a cluster randomized controlled design. Sixteen primary healthcare facilities (clusters) will be randomized in a 1:1 ratio to receive ACT+ (intervention arm, n=8) or standard of care (control arm, n=8). The 9-month intervention period will be followed by quantitative and qualitative evaluation.

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Community Members * 18 years of age or older * Received a positive ADUNU echocardiographic screening result within the past 24 months OR parent/legal guardian of a minor who received a positive ADUNU echocardiographic screening result within the past 24 months Inclusion Criteria: Providers * Employed at an ADUNU-participating facility or confirmatory echo facilities at the time of study * Holds a designated ADUNU role (nurse screener, confirmatory provider, or referral support staff) or is involved in RHD screening, diagnosis or care * Ability to provide informed consent in Acholi, Luo, or English Inclusion Criteria: Regional RHT ACT Nurse Coordinator * Employed as a Regional ACT Nurse at the time of study * Has familiarity with ADUNU program * Ability to provide informed consent in Acholi, Luo, or English Inclusion Criteria: District Health Office Team Members and District RHD Focal Persons * Employed at District Health Office within an ADUNU-participating district * Has familiarity with ADUNU program * Ability to provide informed consent in Acholi, Luo, or English

Exclusion criteria

* No formal

Design outcomes

Primary

MeasureTime frameDescription
Facility-level linkage to confirmation rate9 monthsThe proportion of individuals with a positive ADUNU screening result who complete confirmatory echocardiography within the 9-month intervention period.

Secondary

MeasureTime frameDescription
Time (days) from positive screen to confirmatory echocardiography9 months% providers entering \>90% of screening records OR completing all monthly outreach activities

Countries

Uganda

Contacts

CONTACTIsabella Brigham
isabella.aspromonte@cchmc.org513-517-1307
PRINCIPAL_INVESTIGATORAndrea Beaton

Children's Hospital Medical Center, Cincinnati

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 14, 2026